cmRNAbone

3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients

Programm
Horizon 2020 & sub-programmes
Laufzeit
54 Monate (January 2020 – June 2024)
Projektförderung
≈ €6 million
Projektpartner
11
Technologie-Reifegrad
4-7

Worum es geht

The cmRNAbone project aim to create a novel bone regenerative therapeutic approach based on combination of chemically modified RNAs (cmRNAs)-vectors embedded in a 3D-printed guiding biomaterial ink tailored to patients need.

Koordination

Prof. Martin Stoddart

AO Research Institute Davos, Switzerland

E-Mail senden

Ihre EURICE-Kontakte

Ihr Kontakt
Nadine Drechoux
Senior Research & Impact Manager
E-mail

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

THE COURT betreten